Beijing Tiantan Biological Products revenue and profit fall over 50% YoY
Beijing Tiantan Biological Products reported revenue and profit down over 50% year-over-year, citing industry headwinds and policy changes.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.